Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_assertion evidence source_evidence_literature NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_assertion SIO_000772 16507781 NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_assertion wasDerivedFrom gad-20150221 NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_assertion wasGeneratedBy ECO_0000203 NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.
- gad-20150221 importedOn "2015-02-21" NP61438.RAZ1dzGZ2uJJJep448-zes5a1YAL4_zuqifXgqUyM2m3Y130_provenance.